L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.8 NOK -0.29% Market Closed
Market Cap: 337.4m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Relative Value

The Relative Value of one LYTIX stock under the Base Case scenario is 0.9 NOK. Compared to the current market price of 6.8 NOK, Lytix Biopharma AS is Overvalued by 87%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LYTIX Relative Value
Base Case
0.9 NOK
Overvaluation 87%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
14
Median 3Y
80.8
Median 5Y
79.6
Industry
7.7
Forward
39.1
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-6.9
Industry
22.7
Forward
-2.5
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-6.1
Industry
21.6
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-6
Industry
25.2
vs History
2
vs Industry
10
Median 3Y
3.6
Median 5Y
3.3
Industry
2.5
vs History
31
vs Industry
13
Median 3Y
66.9
Median 5Y
63.2
Industry
7.7
Forward
33.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-3.9
Industry
4.2
Forward
-2.3
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-3.9
Industry
4.1
Forward
-2.3
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4.1
Industry
5.7
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4.1
Industry
3.6
vs History
53
vs Industry
7
Median 3Y
51.1
Median 5Y
45.7
Industry
4.6

Multiples Across Competitors

LYTIX Competitors Multiples
Lytix Biopharma AS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Lytix Biopharma AS
OSE:LYTIX
347.3m NOK 84.5 -3.8 -3.1 -3.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.2B USD 5.8 63.3 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
151.1B USD 4.6 35.4 16.8 31.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.5B USD 11.2 -249 24.8 26.1
US
Gilead Sciences Inc
NASDAQ:GILD
114.4B USD 4 908.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.9 33.2 20.5 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.8B USD 6 17.9 16.2 18.1
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.6 -130.8 -106.2 -77.4
P/E Multiple
Earnings Growth
NO
L
Lytix Biopharma AS
OSE:LYTIX
Average P/E: 211.6
Negative Multiple: -3.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63.3
412%
US
Amgen Inc
NASDAQ:AMGN
35.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -249
42%
US
Gilead Sciences Inc
NASDAQ:GILD
908.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.2
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.8 N/A
EV/EBITDA Multiple
EBITDA Growth
NO
L
Lytix Biopharma AS
OSE:LYTIX
Average EV/EBITDA: 17.3
Negative Multiple: -3.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.8
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.8
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.5
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106.2 N/A
EV/EBIT Multiple
EBIT Growth
NO
L
Lytix Biopharma AS
OSE:LYTIX
Average EV/EBIT: 22.6
Negative Multiple: -3.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -77.4 N/A

See Also

Discover More
Back to Top